Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Life360 (LIF) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Life360 (LIF) over the last 6 years, with Q3 2025 value amounting to $455.7 million.

  • Life360's Cash & Equivalents rose 18666.06% to $455.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $455.7 million, marking a year-over-year increase of 18666.06%. This contributed to the annual value of $159.2 million for FY2024, which is 13090.02% up from last year.
  • Per Life360's latest filing, its Cash & Equivalents stood at $455.7 million for Q3 2025, which was up 18666.06% from $432.7 million recorded in Q2 2025.
  • Over the past 5 years, Life360's Cash & Equivalents peaked at $455.7 million during Q3 2025, and registered a low of $44.0 million during Q3 2022.
  • In the last 5 years, Life360's Cash & Equivalents had a median value of $74.4 million in 2022 and averaged $136.8 million.
  • Per our database at Business Quant, Life360's Cash & Equivalents skyrocketed by 30946.24% in 2021 and then plummeted by 6733.88% in 2022.
  • Over the past 5 years, Life360's Cash & Equivalents (Quarter) stood at $231.0 million in 2021, then tumbled by 67.34% to $75.4 million in 2022, then fell by 8.59% to $69.0 million in 2023, then surged by 130.9% to $159.2 million in 2024, then skyrocketed by 186.2% to $455.7 million in 2025.
  • Its Cash & Equivalents stands at $455.7 million for Q3 2025, versus $432.7 million for Q2 2025 and $168.9 million for Q1 2025.